Patent · US Active

Coated tablet formulations and uses thereof

US8790708B2 · kind B2 · utility

12Cited by
6References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2013
Grant dateJul 29, 2014
Priority date
Expiry dateAug 21, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.